MP77: Prostate Cancer: Epidemiology & Natural History II

Monday, May 1, 2023

9:30 AM – 11:30 AM CST

Location: S504

CE: 1

Poster Session Moderator(s)

Matthew Cooperberg, MD

UCSF Helen Diller Family Comprehensive Cancer Center
James Eastham, MD (he/him/his)

Memorial Sloan Kettering Cancer Center

Presentations:

9:30 AM – 11:30 AM CST

MP77-01: Trends, Outcomes, and Costs of Hemostatic Utilization for Major Urologic Surgery
Poster Presenter: Camilo Arenas Gallo, MD (he/him/his) – Case Western Reserve University
9:30 AM – 11:30 AM CST

MP77-02: High Area Deprivation Index is Associated with De Novo Prostate Cancer Metastasis in Veterans
Poster Presenter: Ananta Wadhwa (she/her/hers) – VA Greater Los Angeles
9:30 AM – 11:30 AM CST

MP77-03: The Effect of Neighborhood Archetype on Prostate Cancer-Specific Mortality for Wisconsin Men
Poster Presenter: Ashanda Esdaille, MD (she/her/hers) – Emory University School of Medicine/Atlanta Vetera
9:30 AM – 11:30 AM CST

MP77-04: Racial disparities in future development of lethal prostate cancer based on PSA levels in midlife
Poster Presenter: Matthew James Davis, MD, MBA
9:30 AM – 11:30 AM CST

MP77-05: Prostate Cancer Trends among Individual Asian and Pacific Islanders (AAPI) Populations in Hawaii
Poster Presenter: Lauren P. Muramoto, MD (she/her/hers)
9:30 AM – 11:30 AM CST

MP77-07: Causal effects of modifiable behaviors on prostate cancer in Europeans and East Asians: a comprehensive Mendelian randomization study
Poster Presenter: Yongle Zhan, PhD – The University of Hong Kong
9:30 AM – 11:30 AM CST

MP77-08: PROSTATE CANCER PRESENTATION IN A COMMUNITY SETTING A DECADE SINCE THE USPSTF GRADE D RECOMMENDATION
Poster Presenter: Franklin David Gaylis, MD
9:30 AM – 11:30 AM CST

MP77-09: Changes in Prostate Specific Antigen Screening Following the 2018 United States Preventive Services Task Force Guidelines and Through the COVID-19 Pandemic
Poster Presenter: Zhiyu (jason) Qian, MD (he/him/his)
9:30 AM – 11:30 AM CST

MP77-10: Stage and Grade Migration of Prostate Cancer During the COVID-19 Pandemic
Poster Presenter: Edoardo Beatrici, MD
9:30 AM – 11:30 AM CST

MP77-11: The Oncologic Risk of MRI-targeted and Systematic Cores in Patients Treated with Radical Prostatectomy
Poster Presenter: Christopher D. Gaffney, MD
9:30 AM – 11:30 AM CST

MP77-12: Clinical decision making in prostate cancer care - Evaluation of a novel guideline conform decision support software
Poster Presenter: Christian Engesser (he/him/his)
9:30 AM – 11:30 AM CST

MP77-13: Outpatient versus Inpatient Robotic Assisted Radical Prostatectomy: Complications, Time Driven Activities Based Costing and Patient Satisfaction
Poster Presenter: Emily Cheng
9:30 AM – 11:30 AM CST

MP77-14: PATIENT AND FACILITY FACTORS ASSOCIATED WITH 90-DAY MORTALITY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER
Poster Presenter: Folawiyo Laditi, BS, MSC
9:30 AM – 11:30 AM CST

MP77-15: Increased Risk of Biochemical Recurrence after Radical Prostatectomy in the Active Surveillance Era
Poster Presenter: Sanjay Das
9:30 AM – 11:30 AM CST

MP77-16: Management of biochemical recurrence and incident metastatic disease after radical prostatectomy for prostate cancer
Poster Presenter: Ted A. Skolarus, MD,FACS,MPH – Department of Surgery, University of Chicago
9:30 AM – 11:30 AM CST

MP77-17: Effect of Type of Definitive Treatment on Race-Based Differences in Prostate Cancer-Specific Survival
Poster Presenter: Nicola Frego, MD
9:30 AM – 11:30 AM CST

MP77-18: The Impact of Testosterone on Urinary Incontinence Following Robot-Assisted Laparoscopic Prostatectomy
Poster Presenter: Larry I. Lipshultz, MD – Baylor College of Medicine
9:30 AM – 11:30 AM CST

MP77-19: Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population-based propensity score matching study
Poster Presenter: Jeongwan Yoo, MD
9:30 AM – 11:30 AM CST

MP77-20: Trends in Definitive Therapy for Prostate Cancer During the COVID-19 Pandemic: A Grade-by-Grade- Analysis
Poster Presenter: Edoardo Beatrici, MD